Recent developments include Clover Health’s Q2 2026 earnings call highlighting continued membership growth and profitability, legal developments related to CMS Star Ratings recalculations, and a cybersecurity incident in July 2026 involving unauthorized access to employee accounts.

• Clover Health reported total revenues of $743.2 million and net income of $28.0 million for Q2 2026, driven by Medicare Advantage membership growth and higher per-member premiums [N1].
• CMS recalculated Clover Health’s 2026 Star Ratings upward for payment year 2027 following a court judgment, increasing PPO and HMO plan ratings to 4.5 Stars [N1].
• A cybersecurity incident in July 2026 involved unauthorized access to certain employee accounts related to member scheduling and broker sales functions; the company believes the incident was contained and is under ongoing investigation [S2].
• Clover Health continues to expand its Medicare Advantage membership, operating in five states and 203 counties with approximately 157,309 members as of June 30, 2026 [N1].
• The company’s adjusted EBITDA increased to $40.9 million for Q2 2026, reflecting improved operational efficiency and revenue growth [N1].

Clover Health’s technology-driven approach to Medicare Advantage plans, centered on the Clover Assistant platform, enables scalable improvements in clinical decision-making and patient care. The platform’s integration with major EHR systems and continuous learning cycle supports ongoing enhancements and provider adoption. Membership growth and improved plan economics have driven revenue increases and profitability improvements in 2026. The company’s wide network and low out-of-pocket costs may attract a broad member base, including underserved populations. External commercialization of Clover Assistant through Counterpart Health offers potential for new revenue streams with low startup costs. Recent CMS Star Ratings recalculations favorably impact Clover’s quality bonus payments, potentially enhancing financial performance.

Clover Health faces risks related to cybersecurity, as evidenced by a July 2026 incident involving unauthorized access to employee accounts, which could lead to regulatory, legal, and reputational consequences. The company operates in a highly regulated environment with ongoing litigation affecting CMS Star Ratings, introducing uncertainty in payment and quality metrics. The benefits expense ratio remains high, reflecting medical claims costs that could pressure margins. The company’s reliance on technology adoption by providers and integration with EHR systems requires ongoing investment and execution. Market competition in Medicare Advantage is intense, and the company’s growth depends on successful expansion into new markets and sustained membership retention.

Clover Health’s moat is anchored in its proprietary Clover Assistant technology platform, which integrates vast and diverse healthcare data sources to deliver personalized, actionable clinical insights to physicians. This platform creates a closed feedback loop that continuously improves clinical decision support through real-time data and machine learning, enhancing care quality and plan performance. The company’s wide physician network and open provider choice differentiate its Medicare Advantage plans from competitors that typically offer narrow networks. Additionally, Clover Health’s focus on underserved markets and high-acuity patients, supported by specialized clinical programs, strengthens its position. The external licensing of Clover Assistant through Counterpart Health extends the platform’s reach and creates potential for high-margin SaaS revenue streams. These factors collectively contribute to a differentiated, technology-driven care model that is difficult for traditional managed care plans to replicate.

• Cybersecurity Risks: A July 2026 social engineering attack led to unauthorized access to certain employee accounts related to member scheduling and broker sales functions. Although contained, such incidents could result in regulatory investigations, litigation, reputational harm, and operational disruptions.
• Regulatory and Litigation Risks: Ongoing litigation related to CMS Star Ratings affects quality bonus payments and introduces uncertainty in reimbursement. Changes in Medicare policy or CMS rules could impact plan economics.
• Operational Execution Risks: The company’s business model depends on provider adoption of Clover Assistant technology and integration with EHR systems. Failure to maintain or expand provider networks or to manage medical claims costs could affect financial performance.
• Market Competition: The Medicare Advantage market is competitive with established insurers. Clover Health’s ability to grow membership and maintain low out-of-pocket costs is critical to sustaining its market position.

• Clover Health operates Medicare Advantage (MA) plans including PPO and HMO products in five states and 203 counties as of June 30, 2026, with approximately 157,309 members.
• The company’s core technology platform is Clover Assistant, a cloud-based software that aggregates data from over 100 sources to provide physicians with data-driven, personalized clinical insights to identify, manage, and treat chronic diseases earlier.
• Clover Assistant is licensed externally as Counterpart Assistant through subsidiary Counterpart Health, which offers SaaS and tech-enabled services to external payors and providers serving Medicare-eligible populations.
• The company’s strategy focuses on improving care for Medicare beneficiaries by empowering physicians with technology, developing wide physician networks, and offering plans with low out-of-pocket costs and wide provider choice.
• Clover Health’s MA plans emphasize wide network access, often offering the same cost-sharing for in-network and out-of-network primary care providers.
• The company operates clinical programs for high-acuity members, including home-based primary care (Clover Home Care), supportive care, care transition support, and behavioral health programs, all powered by Clover Assistant.
• Clover Assistant integrates with major EHR systems such as Epic, Cerner, and Athena to embed clinical decision support into provider workflows.
• The company reported total revenues of $743.2 million for Q2 2026, a 56% increase year-over-year, driven by membership growth and higher per-member premiums.
• Net income for Q2 2026 was $28.0 million, compared to losses in the prior-year period, with adjusted EBITDA of $40.9 million for the quarter.
• At June 30, 2026, Clover Health had cash and cash equivalents of $78.3 million and current assets of $485.4 million against current liabilities of $323.3 million, resulting in a current ratio of 1.5 and a cash ratio of 0.25.
• The company’s insurance benefits expense ratio was approximately 87.6% for Q2 2026, reflecting medical claims and quality improvement expenses relative to premiums earned.
• CMS awarded Clover Health’s PPO and HMO MA plans 3.5 and 4.0 Stars respectively for 2026, with recalculations increasing these to 4.5 Stars for payment year 2027 following a court judgment.
• Clover Health experienced a cybersecurity incident in July 2026 involving unauthorized access to certain employee accounts related to member scheduling and broker sales functions; the company believes the incident was contained and has ongoing investigation.
• The company is remote-first and does not maintain a physical headquarters.
• Recent news highlights include Q2 2026 earnings call, legal developments related to CMS Star Ratings, and membership growth announcements.
• Financial figures and liquidity ratios are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice.